Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Antibe Therapeutics Inc | ATE | Toronto | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.295 | 0.295 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 0.15 - 1.23 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 0.295 | CAD |
Antibe Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
15.26M | 52.62M | - | 6.99M | -19.48M | -0.37 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Antibe Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATE Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.41 | 0.465 | 0.15 | 0.2137221 | 290,438 | -0.115 | -28.05% |
3 Months | 0.91 | 1.08 | 0.15 | 0.447439 | 164,662 | -0.615 | -67.58% |
6 Months | 0.47 | 1.23 | 0.15 | 0.6149036 | 116,478 | -0.175 | -37.23% |
1 Year | 0.55 | 1.23 | 0.15 | 0.5956292 | 67,884 | -0.255 | -46.36% |
3 Years | 4.47 | 4.69 | 0.15 | 1.15 | 82,888 | -4.18 | -93.40% |
5 Years | 0.415 | 7.52 | 0.15 | 1.86 | 108,399 | -0.12 | -28.92% |
Antibe Therapeutics Description
Antibe Therapeutics Inc is leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to target inflammation arising from a wide range of medical conditions. |